… Exogenous hormones have been associated with hemostatic effects, which are well-studied
in cis… the risk of VTE among transgender individuals undergoing cross-sex hormone therapy. …

… Cross-sex hormone therapy typically consists of various estrogen formulations which confer
varying risks of venous thromboembolism (… times as it is a variable that may alter the risk of …

… the hemostatic balance toward thrombosis. The endogenous … , a major complication is
venous thromboembolism (VTE), … The risk of VTE associated with cross-sex hormone treatment …

… marker as the dependent variable and duration of treatment (0, 3 … the percentage change
after 12 months of hormone therapy, … [40], nor the occurrence of venous thromboembolism [11]. …

… Through these combined changes, induction of resistance to … show variable approach to
VTE risk factor assessment [31]. … deep venous thrombosis and EINSTEIN pulmonary embolism …

… associated with venous thromboembolism (VTE) risk. … women, hormones such as oral
contraceptives and hormone therapy (… the changes we observed are likely an effect of the …

… no significant changes in hemostatic laboratory values such as factor VIII levels. While not
… Until research identifies a clear association between hormone therapy and thrombosis risk …

… variables in women with previous venous thromboembolism--results from a randomized, …
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment …

… Many transgender people use hormone therapy to change their … observation that aldosterone
modifies hemostasis and leads to … Variables that have been noted to exacerbate VTE risk …

… Superficial vein thrombosis was excluded from this group. … disease and cancer during
cross-sex hormone therapy in a large … Venous thrombosis with oral postmenopausal hormone …